Posted by Michael Wonder on 26 Oct 2017
Call for anti-HIV drug to be funded
26 October 2017 - The AIDS Foundation says it's a fiscal no-brainier to fully fund a drug that prevents the spread of HIV.
Medsafe has approved use of PrEP, an anti-viral cocktail the US Centers for Disease control says reduces the risk of contracting HIV via sexual contact by 90 percent.
But the $1000/month cost of the drug is not yet funded by PHARMAC.
